No label defined (Q3312831)

From EU Knowledge Graph
Revision as of 22:15, 24 October 2021 by DG Regio (talk | contribs) (‎Created claim: summary (P836): With the innovative screening and technology platform, parenteral (sterile) medicines with insoluble chemical and biological agents can be developed and manufactured using nanotechnology faster, more efficiently and cost-effectively., translated_summary)
Jump to navigation Jump to search
Project Q3312831 in Germany
Language Label Description Also known as
English
No label defined
Project Q3312831 in Germany

    Statements

    country
    Germany
    0 references
    EU contribution
    516,561.12 Euro
    0 references
    budget
    1,067,495.6 Euro
    0 references
    co-financing rate
    48.39 percent
    0 references
    start time
    17 March 2020
    0 references
    end time
    31 March 2022
    0 references
    beneficiary name (string)
    HWI pharma services GmbH
    0 references
    coordinate location

    49°13'20.17"N, 8°21'59.72"E
    0 references
    postal code
    76761
    0 references
    summary
    Mit der innovativen Screening- und Technologie-Plattform lassen sich parenterale (sterile) Arzneimittel mit schwerlöslichen chemischen und biologischen Wirkstoffen mittels Nanotechnologie schneller, effizienter und kostengünstiger entwickeln und herstellen. (German)
    0 references
    With the innovative screening and technology platform, parenteral (sterile) medicines with insoluble chemical and biological agents can be developed and manufactured using nanotechnology faster, more efficiently and cost-effectively. (English)
    point in time
    25 October 2021
    0 references
    location (string)
    Germersheim
    0 references

    Identifiers

    German Kohesio ID
    DE_TEMPORARY_15618
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q3312831&oldid=13462707"